Hsinchu, Taiwan, July 6th, 2022 To Eden Biologics Investors, Partners, Colleagues and Friends: I would like to take this opportunity to inform our shareholders that our CDMO Business Unit has... read more →
Hsinchu, Taiwan, September 1st, 2021 - Eden Biologics, Inc., a leading global biotechnology company based in Hsinchu, Taiwan, announced on September 1st, the appointment of Dr. Steve Lee, an accomplished... read more →
We’ve once again achieved a huge corporate milestone and are excited to share the great news with all of you! Our EB-CLIN-1001-03 Phase 3 Clinical Trial for our leading Biosimilar... read more →
Hsinchu, Taiwan, July 9th, 2021 – Earlier this week, the United States Department of Justice announced that it has filed criminal charges against Racho Jordanov and Rose Lin, former employees... read more →
Hsinchu, Taiwan, March 15th, 2021 – Eden Biologics is honored to announce the addition of Dr. Scott Liu as a member of the Eden Board of Directors. Effective March 15,... read more →
Hsinchu, Taiwan, 25th February, 2021 – Eden Biologics, Inc., a global frontrunner in biological drug development and manufacturing platform technologies, today announced completion of enrollment for their Phase 1 comparative... read more →
Hsinchu, Taiwan, February 19, 2021 – JHL Biotech, Inc., a global frontrunner in large-molecule biological drug development and manufacturing platform technologies, is excited to announce today that it has changed... read more →
Melbourne, Australia and Hsinchu, Taiwan, 22 May 2020 – Q-Sera Pty Ltd is pleased to announce a collaboration with JHL Biotech, Inc. (Taiwan) to produce high yielding recombinant ecarin for... read more →
Hsinchu, Taiwan, May 18th, 2020 – JHL Biotech, Inc. today announced that the first group of subjects has been randomized and dosed last week in the company's Australian Phase I Clinical... read more →